Now Reading: Ropes & Gray Advises QHP Capital on Formation of Continuation Fund for Catalyst Clinical Research
1
-
01
Ropes & Gray Advises QHP Capital on Formation of Continuation Fund for Catalyst Clinical Research
www.ropesgray.com. (PRNewsFoto/Ropes & Gray LLP)
Ropes & Gray Advises QHP Capital on Formation of Continuation Fund for Catalyst Clinical Research
Ropes & Gray advised QHP Capital L.P. (QHP) on the formation of a single asset continuation fund called the “Catalyst SPV,” backing Catalyst Clinical Research LLC (Catalyst).
QHP is a Raleigh-based private equity firm which manages the NovaQuest Private Equity family of funds. Catalyst is a global contract research organization providing full-service clinical development support for oncology-focused biotechs. The formation was announced on Nov. 1 in a press release.
The Ropes & Gray team that represented QHP was led by asset management partner Peter Laybourn and private equity partners Greg Bauer and Martin Ruhaak. The team also included tax partner Jim Brown.
